BLOG

Saturday, February 22, 2020

Biocon gets 3 observations from US health regulator for Malaysia facility

The FDA has set a target action date for its Insulin Glargine application in June 2020

from Companies https://ift.tt/37KyXiZ
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...